1. Home
  2. MIR vs CORT Comparison

MIR vs CORT Comparison

Compare MIR & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mirion Technologies Inc.

MIR

Mirion Technologies Inc.

HOLD

Current Price

$18.83

Market Cap

4.6B

Sector

Technology

ML Signal

HOLD

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

HOLD

Current Price

$42.51

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MIR
CORT
Founded
2005
1998
Country
United States
United States
Employees
3281
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
3.7B
IPO Year
N/A
2001

Fundamental Metrics

Financial Performance
Metric
MIR
CORT
Price
$18.83
$42.51
Analyst Decision
Strong Buy
Buy
Analyst Count
8
6
Target Price
$27.25
$107.20
AVG Volume (30 Days)
3.4M
1.8M
Earning Date
04-28-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.82
Revenue
N/A
$761,407,000.00
Revenue This Year
$24.16
$26.08
Revenue Next Year
$7.31
$31.04
P/E Ratio
$195.00
$51.84
Revenue Growth
N/A
12.79
52 Week Low
$12.00
$28.66
52 Week High
$30.28
$91.00

Technical Indicators

Market Signals
Indicator
MIR
CORT
Relative Strength Index (RSI) 44.54 65.95
Support Level N/A $32.95
Resistance Level $22.23 $47.06
Average True Range (ATR) 1.02 2.67
MACD 0.09 1.20
Stochastic Oscillator 65.73 56.92

Price Performance

Historical Comparison
MIR
CORT

About MIR Mirion Technologies Inc.

Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

Share on Social Networks: